ALEC
STOCK SCORE
ALEC
STOCK SCORE
Target 1Y
Login to View
Target 6M
Login to View
Valuation
Login to View
Max Portfolio %
Login to View
Last 7 days
22.9%
Last 30 days
21.2%
Last 90 days
17.2%
Trailing 12 Months
92.4%
ALEC RSI Chart
Valuation
Login to View
Max Portfolio %
Login to View
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Target 1Y
Login to View
Target 6M
Login to View
How Alector Inc generates revenue and covers its expenses, based on the latest reported earnings.
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2026 | 18.4M | 13.9M | - | - |
| 2025 | 88.3M | 81.1M | 69.0M | 21.0M |
| 2024 | 96.4M | 55.3M | 61.5M | 100.6M |
| 2023 | 125.7M | 102.1M | 96.3M | 97.1M |
| 2022 | 227.4M | 300.7M | 133.2M | 133.6M |
| 2021 | 18.0M | 21.4M | 197.9M | 207.1M |
| 2020 | 22.8M | 19.0M | 22.2M | 21.1M |
| 2019 | 28.4M | 28.2M | 24.4M | 21.2M |
| 2018 | 8.4M | 15.2M | 21.6M | 27.7M |
| 2017 | 1.2M | 2.1M | 2.9M | 3.7M |
| 2016 | - | - | - | 416.0K |
| CEO | Dr. Arnon Rosenthal Ph.D. |
|---|---|
| WEBSITE | alector.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 239 |